TA
Third Arc Bio
United States · Biotech
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A+ | $52M | AbbVie Ventures — Role not disclosedabrdn — Role not disclosedAlderline Group — Role not disclosedAndreessen Horowitz (a16z) — Role not disclosedBVF Partners LP — Role not disclosedGalapagos NV — Role not disclosedGoldman Sachs Alternatives Life Sciences — Role not disclosedHillhouse Investment — Role not disclosedMarshall Wace — Role not disclosedOmega Funds — Role not disclosedT. Rowe Price Associates — Role not disclosed |